Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Bespak – 21.05.2025
Stoelzle – 15th May 2025

The EU Medical Devices Regulation and its Market Impact Under the Spotlight

The global drug-device combination products market was estimated to be worth US$ 123.5 billion in 2020 and is forecast to grow at a CAGR of 8.2% between now and 2027. The new combination products entering the market don’t just include traditional parenterals, but autoinjectors and inhalers too, as well as other next generation devices. Nadine Kasidas-Neale at Recipharm explains the incoming changes to EU medical device regulations and their impact on pharmaceutical companies developing drug delivery devices, including autoinjectors for the EU market.

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025